JNJ-78278343, JNJ-95298177 clinical trials

A study of JNJ-78278343 in combination with JNJ-95298177 for treatment of prostate cancer

This study is testing two new medicines, JNJ-78278343 and JNJ-95298177, together for advanced prostate cancer. Researchers want to find the safest and most effective dose in men whose cancer has spread and is no longer responding well to standard hormone treatments.